Login / Signup

Null-type SH2B3 mutations are potential drivers in a subset of Ph-negative myeloproliferative neoplasms.

Xi ZhangYi DingPeng LiKirk BourgeoisAruna RanganJennifer L HerrickAnimesh D PardananiDong ChenDavid ViswanathaRong HeGang Zheng
Published in: American journal of hematology (2024)
Keyphrases
  • human health
  • risk assessment